ARCHIVES

ODAC Member Critical Of Amgen For Price Incentives.

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | March 21, 2008

Download PDF Visit The Full Archive

Related Articles

NCI Expects Improved Communications to Result from Consolidation of Offices

May 12, 2000

Survivorship Research RFA To Be Reissued; Biomedical Imaging Institute Names 10 to Advisory Council

November 29, 2002

In Brief: Longmire Reappointed to Panel; New Organ System Group For Brain-CNS Tumors Asked

April 26, 1985

Grants Funding: FY(& Year-End Report By NCI On Paylines

October 10, 1997

Investigators Plan To Interview DeVita, Mendelsohn on C225 Development

July 5, 2002

Femara Better Suppressor Of Estrogen, Study Finds

February 22, 2002